Fibromyalgia
📧 Sign up to get email alerts when something new happens for Fibromyalgia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-04-11Clinical Trial Update: CBD (Cannabidiol)/THC (Tetrahydrocannabinol) Solution as a Pharmacological Strategy for Patients With Fibromyalgia (FibroCann) [Phase 2, Phase 3]
A phase 2/phase 3 clinical trial investigating CBD/THC solution as a pharmacological strategy for fibromyalgia is underway, with unknown sta…
-
FDA approval · 2022-03-22FDA Approved: PREGABALIN — Original Application (Advagen Pharma Ltd.)
FDA approved Pregabalin under an Original Application for Advagen Pharma Ltd., authorizing the generic product.
-
FDA approval · 2022-03-08FDA Approved: PREGABALIN — Original Application (Eskayef Pharmaceuticals Limited)
FDA approved Eskayef Pharmaceuticals Limited's original application for generic pregabalin (ANDA212988).
-
CLINICAL_TRIALS trial_result · 2022-03-04Clinical Trial Update: Phase 2 Study of TD-9855 to Treat Fibromyalgia [Phase 2]
Phase 2 trial of TD-9855 in fibromyalgia has completed with results posted.
-
FDA approval · 2022-02-18FDA Approved: PREGABALIN — Original Application (Patrin Pharma, Inc.)
FDA approved an original application for pregabalin from Patrin Pharma, making a generic version available. This marks the approval of a gen…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-01-25FDA Approved: DULOXETINE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for a generic duloxetine hydrochloride product from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2021-10-06Clinical Trial Update: Cyclobenzaprine Extended Release (ER) for Fibromyalgia [Phase 4]
Phase 4 trial of cyclobenzaprine extended-release for fibromyalgia was terminated, with results posted in 2021.
-
FDA approval · 2021-09-29FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (AiPing Pharmaceutical, Inc.)
FDA approved a supplemental application for Amitriptyline Hydrochloride, a generic product submitted by AiPing Pharmaceutical, Inc., under t…
-
FDA approval · 2021-09-20FDA Approved: SAVELLA — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for SAVELLA (milnacipran hydrochloride) from Allergan, updating the product labeling.
-
CLINICAL_TRIALS trial_result · 2021-08-30Clinical Trial Update: Use of Repetitive Transcranial Magnetic Stimulation to Augment Hypnotic Analgesia [NA]
This ClinicalTrials.gov update notes the completion of a study evaluating repetitive transcranial magnetic stimulation to augment hypnotic a…
-
CLINICAL_TRIALS trial_result · 2021-08-02Clinical Trial Update: Probiotic VSL#3 for the Treatment of Gastrointestinal Symptoms Associated to Fibromyalgia [NA]
Completed clinical trial evaluating probiotic VSL#3 for gastrointestinal symptoms in fibromyalgia; results posted.
-
FDA approval · 2021-07-23FDA Approved: DRIZALMA SPRINKLE — Supplemental Application (SUN PHARMACEUTICAL INDUSTRIES, INC.)
The FDA approved a supplemental application for Drizalma Sprinkle, a duloxetine product, expanding the label to include a sprinkle-form dosa…
-
FDA approval · 2021-07-15FDA Approved: PREGABALIN — Original Application (Tris Pharma Inc)
The FDA approved Tris Pharma's original Abbreviated New Drug Application for pregabalin, allowing a generic pregabalin product to enter the …
-
FDA approval · 2021-05-19FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved Amitriptyline hydrochloride as an original-application generic from Unichem Pharmaceuticals (USA), Inc. (ANDA 214548).
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: Suvorexant in Insomnia Co-morbid With Fibromyalgia [Phase 4]
Phase 4 trial update on suvorexant for insomnia co-morbid with fibromyalgia; study terminated with posted results.
-
FDA approval · 2021-04-13FDA Approved: PREGABALIN — Original Application (Novadoz Pharmaceuticals LLC)
FDA approves the original abbreviated new drug application for pregabalin from Novadoz Pharmaceuticals LLC, enabling a generic version of pr…
-
CLINICAL_TRIALS trial_result · 2021-03-03Clinical Trial Update: A Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia [Phase 2]
Phase 2 trial evaluating the analgesic efficacy and safety of ASP0819 in fibromyalgia has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2021-01-26Clinical Trial Update: A Controlled Pregabalin Trial In Fibromyalgia [Phase 3]
A Phase 3 controlled trial of pregabalin in fibromyalgia has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-25Clinical Trial Update: A Study of the Efficacy and Safety of Pregabalin for the Treatment of Fibromyalgia [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of pregabalin for fibromyalgia has been completed.
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: An Open-Label Trial of Pregabalin in Patients With Fibromyalgia [Phase 3]
Open-label Phase 3 trial examining pregabalin in patients with fibromyalgia has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: A Safety Study Of Pregabalin In Fibromyalgia [Phase 3]
A Phase 3 safety study of pregabalin in fibromyalgia has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Safety and Efficacy Study of Pregabalin in Fibromyalgia [Phase 3]
Phase 3 trial update evaluating safety and efficacy of pregabalin in fibromyalgia has been completed.
-
CLINICAL_TRIALS trial_result · 2021-01-05Clinical Trial Update: Eszopiclone in the Treatment of Insomnia and Fibromyalgia [Phase 4]
Phase 4 clinical trial update on eszopiclone for fibromyalgia and insomnia has completed with results posted.
-
FDA approval · 2020-12-30FDA Approved: DULOXETINE — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' supplemental application for duloxetine (ANDA204343), enabling the continued marketing of the gener…
-
CLINICAL_TRIALS research · 2020-12-17Clinical Trial Update: Developing an Activity Pacing Framework: Feasibility and Acceptability
A completed clinical trial evaluating the feasibility and acceptability of an activity pacing framework for chronic pain conditions, includi…